North America is expected to dominate the global neurology devices market in the near future
The prevalence rate of neurological disorders is high around the globe. This factor is expected to augment the growth of the global neurology devices market over the forecast period. According to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Growing government initiatives in the form of funding in the R&D of neurological disorders is again uplifting the growth of the neurology devices market. For instance, in December 2019, the U.S. Congress granted US$ 350 million annual appropriations for R&D in Alzheimer’s and dementia. Recently, Patients suffering from Covid-19 have reportedly demonstrated neurologic symptoms, this is expected to create lucrative opportunities for market growth. For example, in April 2020, researchers at the Union Hospital and Huazhong University of Science and Technology in Wuhan, China, reported that over a third of 214 confirmed COVID-19 cases in China had neurologic s...